- Home
- SOTK vs IMMX Comparison
SOTK vs IMMX Comparison
Compare SOTK & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- IMMX
- Stock Information
- Founded
- SOTK 1975
- IMMX 2014
- Country
- SOTK United States
- IMMX United States
- Employees
- SOTK N/A
- IMMX N/A
- Industry
- SOTK Industrial Machinery/Components
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- SOTK Technology
- IMMX Health Care
- Exchange
- SOTK Nasdaq
- IMMX Nasdaq
- Market Cap
- SOTK 61.8M
- IMMX 61.1M
- IPO Year
- SOTK 1987
- IMMX 2021
- Fundamental
- Price
- SOTK $3.91
- IMMX $2.00
- Analyst Decision
- SOTK Buy
- IMMX Strong Buy
- Analyst Count
- SOTK 1
- IMMX 1
- Target Price
- SOTK $7.50
- IMMX $7.00
- AVG Volume (30 Days)
- SOTK 31.9K
- IMMX 135.6K
- Earning Date
- SOTK 01-13-2025
- IMMX 11-12-2024
- Dividend Yield
- SOTK N/A
- IMMX N/A
- EPS Growth
- SOTK N/A
- IMMX N/A
- EPS
- SOTK 0.07
- IMMX N/A
- Revenue
- SOTK $20,151,145.00
- IMMX N/A
- Revenue This Year
- SOTK $6.11
- IMMX N/A
- Revenue Next Year
- SOTK $9.27
- IMMX $200.00
- P/E Ratio
- SOTK $57.01
- IMMX N/A
- Revenue Growth
- SOTK 8.40
- IMMX N/A
- 52 Week Low
- SOTK $3.50
- IMMX $1.26
- 52 Week High
- SOTK $6.07
- IMMX $5.39
- Technical
- Relative Strength Index (RSI)
- SOTK 44.52
- IMMX 45.76
- Support Level
- SOTK $3.71
- IMMX $1.89
- Resistance Level
- SOTK $4.59
- IMMX $2.49
- Average True Range (ATR)
- SOTK 0.44
- IMMX 0.16
- MACD
- SOTK -0.01
- IMMX -0.04
- Stochastic Oscillator
- SOTK 18.65
- IMMX 21.67
About SOTK Sono-Tek Corporation
Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.